The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor (AZD6738) as a single agent and in combination with palliative radiation therapy in patients with solid tumours.
 
Magnus Dillon
No Relationships to Disclose
 
Sally Ellis
No Relationships to Disclose
 
Lorna Grove
Consulting or Advisory Role - Amgen
 
Lyndall McLellan
No Relationships to Disclose
 
Glen Clack
Employment - AstraZeneca
Leadership - Ailse Oncology
Stock and Other Ownership Interests - AstraZeneca
 
Dr Simon Smith
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
Patents, Royalties, Other Intellectual Property - AstraZeneca
 
Jennifer Laude
No Relationships to Disclose
 
Zaid Viney
No Relationships to Disclose
 
Sola Adeleke
No Relationships to Disclose
 
George Lazaridis
No Relationships to Disclose
 
James F. Spicer
Honoraria - Boehringer Ingelheim; Lilly; Lytix Biopharma; Pierre Fabre; Roche; Shionogi
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; Shionogi
Research Funding - GlaxoSmithKline; Quintiles
Travel, Accommodations, Expenses - Boehringer Ingelheim; Merck
 
Martin David Forster
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Clovis Oncology; Lilly; Merck; Novartis; Pfizer
Travel, Accommodations, Expenses - Boehringer Ingelheim; Lilly; Merck; Merck Sharp & Dohme; Pfizer; Roche
 
Kevin J. Harrington
Honoraria - Amgen; Celgene; Merck Sharp & Dohme; Oncos Therapeutics
Consulting or Advisory Role - Amgen (Inst); Merck Sharp & Dohme; Viralytics (Inst)
Speakers' Bureau - Amgen; Merck Sharp & Dohme
Research Funding - AstraZeneca (Inst); Genelux (Inst); Oncolytics (Inst); Viralytics (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim